Terri Johnson

416 total citations
7 papers, 126 citations indexed

About

Terri Johnson is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Plant Science. According to data from OpenAlex, Terri Johnson has authored 7 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 2 papers in Otorhinolaryngology and 2 papers in Plant Science. Recurrent topics in Terri Johnson's work include Cystic Fibrosis Research Advances (7 papers), Tracheal and airway disorders (4 papers) and Nematode management and characterization studies (2 papers). Terri Johnson is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Tracheal and airway disorders (4 papers) and Nematode management and characterization studies (2 papers). Terri Johnson collaborates with scholars based in United States. Terri Johnson's co-authors include Karen McCoy, Shahid Sheikh, Frederick R. Long, Don Hayes, Nancy A. Ryan‐Wenger, Mariah Eisner, Shasha Bai, Courtney Gushue, Mai‐Lan Ho and Grace Paul and has published in prestigious journals such as CHEST Journal, Pediatric Pulmonology and Journal of Cystic Fibrosis.

In The Last Decade

Terri Johnson

7 papers receiving 126 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Terri Johnson United States	6	123	17	13	11	10	7	126
Raj K Rajakulasingam United Kingdom	4	64 0.5×	8 0.5×	8 0.6×	77 7.0×	4 0.4×	7	112
Daniel Laorden Spain	5	33 0.3×	5 0.3×	5 0.4×	37 3.4×	3 0.3×	21	54
Anne Sophie Gamez France	6	73 0.6×	1 0.1×	17 1.3×	27 2.5×	6 0.6×	10	99
Rola Abou‐Taam France	4	87 0.7×		8 0.6×	71 6.5×	10 1.0×	8	131
Freda Yang United Kingdom	5	47 0.4×	2 0.1×	15 1.2×	75 6.8×	7 0.7×	9	91
T. Bieber Germany	2	18 0.1×	35 2.1×	21 1.6×	67 6.1×	2 0.2×	3	109
C Korais Greece	4	14 0.1×	7 0.4×	24 1.8×	3 0.3×	9 0.9×	7	27
Sook Yin Loh United Kingdom	2	26 0.2×	24 1.4×	11 0.8×	6 0.5×		3	41
A. Valero Spain	2	46 0.4×	7 0.4×	2 0.2×	84 7.6×	5 0.5×	2	102
Yoshihisa Tokunaga Japan	5	38 0.3×		6 0.5×	33 3.0×	5 0.5×	10	63

Countries citing papers authored by Terri Johnson

Since Specialization

Citations

This map shows the geographic impact of Terri Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terri Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terri Johnson more than expected).

Fields of papers citing papers by Terri Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terri Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terri Johnson. The network helps show where Terri Johnson may publish in the future.

Co-authorship network of co-authors of Terri Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Terri Johnson. A scholar is included among the top collaborators of Terri Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terri Johnson. Terri Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gushue, Courtney, Mariah Eisner, Shasha Bai, et al.. (2023). Impact of Elexacaftor–Tezacaftor–Ivacaftor on lung disease in cystic fibrosis. Pediatric Pulmonology. 58(8). 2308–2316. 17 indexed citations

2.

McCoy, Karen, et al.. (2023). Impact of chronic medication de-escalation in patients with cystic fibrosis taking elexacaftor, tezacaftor, ivacaftor: A retrospective review. Journal of Cystic Fibrosis. 23(1). 32–37. 7 indexed citations

3.

Sheikh, Shahid, Mai‐Lan Ho, Mariah Eisner, et al.. (2023). Elexacaftor-Tezacaftor-Ivacaftor Therapy for Chronic Sinus Disease in Cystic Fibrosis. JAMA Otolaryngology–Head & Neck Surgery. 149(12). 1075–1075. 8 indexed citations

4.

McCoy, Karen, et al.. (2023). Clinical change 2 years from start of elexacaftor‐tezacaftor‐ivacaftor in severe cystic fibrosis. Pediatric Pulmonology. 58(4). 1178–1184. 19 indexed citations

5.

Sheikh, Shahid, Rodney D. Britt, Aiman Khan, et al.. (2021). IMPACT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATOR ELEXACAFTOR-TEZACAFTOR-IVACAFTOR ON LUNG FUNCTION, BMI, BACTERIAL COLONIZATION, AND ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH CYSTIC FIBROSIS. CHEST Journal. 160(4). A1446–A1447. 2 indexed citations

6.

Sheikh, Shahid, Frederick R. Long, Karen McCoy, et al.. (2014). Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation. Journal of Cystic Fibrosis. 14(1). 84–89. 39 indexed citations

7.

Sheikh, Shahid, Frederick R. Long, Karen McCoy, et al.. (2014). Ivacaftor improves appearance of sinus disease on computerised tomography in cystic fibrosis patients with G551D mutation. Clinical Otolaryngology. 40(1). 16–21. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact